Standout Papers
Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Suppression of Aging in Mice by the Hormone Klotho
2005 StandoutScience
Complement Factor H Polymorphism and Age-Related Macular Degeneration
2005 StandoutScience
Loss of cryptochrome reduces cancer risk in p53 mutant mice
2009 StandoutNobel
Obesity and Metabolic Syndrome in Circadian Clock Mutant Mice
2005 StandoutScience
Primary Prevention of Cardiovascular Mortality and Events With Statin Treatments
2008
Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170 255 patients from 76 randomized trials
2010
Adherence with statins in a real-life setting is better when associated cardiovascular risk factors increase: a cohort study
2011
Cardiac Care for Older Adults
2011
Haplotypes in the human Foxo1a and Foxo3a genes; impact on disease and mortality at old age
2007
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Mind versus metabolism in the control of food intake and energy balance
2004
The safety of statins in clinical practice
2007
Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritides
2000
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
2007 StandoutNature
Fully integrated wearable sensor arrays for multiplexed in situ perspiration analysis
2016 StandoutNature
Acute coronary syndromes and diabetes: is intensive lipid lowering beneficial? Results of the PROVE IT-TIMI 22 trial
2006
Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention
2009
Effect of Statin Therapy on the Progression of Common Carotid Artery Intima-Media Thickness: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
2012
Meta-Analysis of the Relationship Between Non–High-Density Lipoprotein Cholesterol Reduction and Coronary Heart Disease Risk
2009
Drug Treatment of Hyperlipidemia in Women
2004
Vascular dementia
2015 Standout
Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial
2003
The Cost Effectiveness of Statin Therapies in Spain in 2010, after the Introduction of Generics and Reference Prices
2010
Low density lipoprotein cholesterol, statins and cardiovascular events: a meta–analysis
2006
Central nervous system control of food intake and body weight
2006 StandoutNature
Long‐term Cardiac Outcomes in Renal Transplant Recipients Receiving Fluvastatin: The ALERT Extension Study
2005
Pathogenesis and therapy of psoriasis
2007 StandoutNature
Poor Expression of T Cell-Derived Cytokines and Activation and Proliferation Markers in Early Rheumatoid Synovial Tissue
1998
Structure–based design and characterization of exocyclic peptidomimetics that inhibit TNFα binding to its receptor
1997
Statins for Primary Prevention of Cardiovascular Mortality in Women: A Systematic Review and Meta-Analysis
2009
Effects of thyrotoxicosis and selective hepatic autonomic denervation on hepatic glucose metabolism in rats
2008
Effect of the Magnitude of Lipid Lowering on Risk of Elevated Liver Enzymes, Rhabdomyolysis, and Cancer
2007
Age and gender bias in statin trials
2001
The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment
2005 Standout
Exercise‐associated hyponatremia: A review
2001
Impact of gender in primary prevention of coronary heart disease with statin therapy: A meta-analysis
2008
Reductions in circulating anabolic hormones induced by sustained sleep deprivation in rats
2004
Intensive Statin Therapy and the Risk of Hospitalization for Heart Failure After an Acute Coronary Syndrome in the PROVE IT–TIMI 22 Study
2006
Effects of a Dietary Portfolio of Cholesterol-Lowering Foods vs Lovastatin on Serum Lipids and C-Reactive Protein
2003
Niacin and fibrates in atherogenic dyslipidemia: Pharmacotherapy to reduce cardiovascular risk
2010
Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial
2006
Cytokines in autoimmunity
1996
Resistance to thyroid hormone is associated with raised energy expenditure, muscle mitochondrial uncoupling, and hyperphagia
2010
Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis
2001 Standout
Baseline Characteristics of Participants in the JUPITER Trial, A Randomized Placebo-Controlled Primary Prevention Trial of Statin Therapy Among Individuals With Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein
2007
Evolving concepts of rheumatoid arthritis
2003 StandoutNature
The Clinical and Economic Burden of Nonadherence with Antihypertensive and Lipid-Lowering Therapy in Hypertensive Patients
2008
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
2010 Standout
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
1998 StandoutNature
Cardiovascular and Cancer Mortality in Very Elderly Post-Myocardial Infarction Patients Receiving Statin Treatment
2010
Relation of Different Measures of Low-Density Lipoprotein Cholesterol to Risk of Coronary Artery Disease and Death in a Meta-Regression Analysis of Large-Scale Trials of Statin Therapy
2010
Intensive Lowering of Low-Density Lipoprotein Cholesterol Levels for Primary Prevention of Coronary Artery Disease
2009
Lack of Effect of Lowering LDL Cholesterol on Cancer: Meta-Analysis of Individual Data from 175,000 People in 27 Randomised Trials of Statin Therapy
2012
Pharmacodynamic and pharmacokinetic response to anti-tumor necrosis factor-α monoclonal antibody (infliximab) treatment of moderate to severe psoriasis vulgaris
2003
Insulin resistance and compensatory hyperinsulinemia
2003
Meta-Analysis of Cardiovascular Outcomes Trials Comparing Intensive Versus Moderate Statin Therapy
2006
Statin Use and Incident Frailty in Women Aged 65 Years or Older: Prospective Findings From the Women's Health Initiative Observational Study
2008
Impact of Systemic Hypertension on the Cardiovascular Benefits of Statin Therapy—A Meta-Analysis
2008
Statin Safety: A Systematic Review
2006
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
Outcomes of Using High- or Low-Dose Atorvastatin in Patients 65 Years of Age or Older with Stable Coronary Heart Disease
2007
Primary Prevention of Cardiovascular Disease with Statins in the Elderly
2014
Cardiovascular Event Reduction and Adverse Events Among Subjects Attaining Low-Density Lipoprotein Cholesterol <50 mg/dl With Rosuvastatin
2011
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
2003 Standout
The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials
2009
Novel neural pathways for metabolic effects of thyroid hormone
2009
The immunology of exceptional individuals: the lesson of centenarians
1995
Prevention of Cardiovascular Disease in Persons with Type 2 Diabetes Mellitus: Current Knowledge and Rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
2007
A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis
2000 Standout
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
2020 StandoutNobel
Biochemical Analysis of the Canonical Model for the Mammalian Circadian Clock
2011 StandoutNobel
A clockwork web: circadian timing in brain and periphery, in health and disease
2003
New and emerging data from clinical trials of statins
2004
Statins and All-Cause Mortality in High-Risk Primary Prevention
2010
Safety of Aggressive Lipid Management
2007
Statin-Associated Myopathy
2003
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Pleiotropic Effects of Statins
2010
Pravastatin and cognitive function in the elderly. Results of the PROSPER study
2009
Effects of statins on stroke prevention in patients with and without coronary heart disease: A meta-analysis of randomized controlled trials
2004
Prevention of Coronary and Stroke Events with Atorvastatin in Hypertensive Patients who have Average or Lower-than-Average Cholesterol Concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial???Lipid Lowering Arm (ASCOT-LLA)
2004
Role of plant polyphenols in genomic stability
2001
Inhibitor of nuclear factor ?B kinase ? is a key regulator of synovial inflammation
2001
Benefits of Statins in Elderly Subjects Without Established Cardiovascular Disease
2013
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
2008 Standout
Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy
2010
Cancer-related inflammation
2008 StandoutNature
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
2004 Standout
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
2003 StandoutNature
Alzheimer's disease: the cholesterol connection
2003
Mevalonate pathway: A review of clinical and therapeutical implications
2007
Pathways towards and away from Alzheimer's disease
2004 StandoutNature
Statins and the Risk of Colorectal Cancer
2005
Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S)
2004
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Statins: An essential component in the management of carotid artery disease
2007
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics
2008
Hyponatremia
2000 Standout
Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004—BHS IV
2004
Coronary heart disease prevention and age inequalities: the first year of the National Service Framework for CHD.
2005
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis
2011 StandoutNobel
Dissecting racial bias in an algorithm used to manage the health of populations
2019 StandoutScience
Statin Therapy and the Risk of Intracerebral Hemorrhage
2012
TNF-R1 Signaling: A Beautiful Pathway
2002 StandoutScience
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
2006 Standout
Pravastatin and the Development of Diabetes Mellitus
2001
Usefulness of Pravastatin in Primary Prevention of Cardiovascular Events in Women
2008
Lymphocyte Homing and Homeostasis
1996 StandoutScience
Thyroid hormone modulates glucose production via a sympathetic pathway from the hypothalamic paraventricular nucleus to the liver
2009
Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack
2008
Anti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?
2001
Pharmacological and surgical treatment of obesity.
2004
The Thermogenic Effect of Thyroid Hormone and Its Clinical Implications
2003
Benefits of Pravastatin on Cardiovascular Events and Mortality in Older Patients with Coronary Heart Disease Are Equal to or Exceed Those Seen in Younger Patients: Results from the LIPID Trial
2001
Part 9: Post–Cardiac Arrest Care
2010 Standout
TNF Inhibition Rapidly Down-Regulates Multiple Proinflammatory Pathways in Psoriasis Plaques
2005
Angiotensin‐Converting Enzyme Inhibitor and Statin Use and Incident Mobility Limitation in Community‐Dwelling Older Adults: The Health, Aging and Body Composition Study
2011
Cardiovascular risk estimation in older persons: SCORE O.P.
2015
Congenital Growth Hormone (GH) Deficiency and Atherosclerosis: Effects of GH Replacement in GH-Naive Adults
2007
Statins for the primary prevention of cardiovascular disease
2013
Statins in Stroke Prevention and Carotid Atherosclerosis
2004
Increase in TNF-α and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)
2005 StandoutNobel
Control of skin cancer by the circadian rhythm
2011 StandoutNobel
Regulation of apoptosis by the circadian clock through NF-κB signaling
2011 StandoutNobel
Thyroid Hormone Regulation of Metabolism
2014 Standout
Association of human aging with a functional variant of klotho
2002
Clinical Implications of Obesity With Specific Focus on Cardiovascular Disease
2004
Health Care–Associated Bloodstream Infections
2003
Rosuvastatin for Primary Prevention in Older Persons With Elevated C-Reactive Protein and Low to Average Low-Density Lipoprotein Cholesterol Levels: Exploratory Analysis of a Randomized Trial
2010
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
2004
Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions
2016
Regulation of metabolism by the innate immune system
2015
A systematic review and economic evaluation of statins for the prevention of coronary events
2007
Mild cognitive impairment
2005
Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions
2004
Role of C-Reactive Protein in Cardiovascular Disease
2003
Effects of Intensive Glucose Lowering in Type 2 Diabetes
2008 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
The role of T cells in the immunopathogenesis of rheumatoid arthritis. New perspectives
1997
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial
2003
Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis
2008
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
2012 Standout
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
2004 Standout
Is it Time for a Cardiovascular Primary Prevention Trial in the Elderly?
2006
Part 14: Pediatric Advanced Life Support
2010 Standout
Extending Healthy Life Span—From Yeast to Humans
2010 StandoutScience
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
2005 Standout
Works of A. Edo Meinders being referenced
A Prospective Study of Pravastatin in the Elderly at Risk (PROSPER): Screening Experience and Baseline Characteristics
2002
Expression of the Activation Antigen CD27 in Rheumatoid Arthritis
1996
INCREASED EXPRESSION OF IL-15 IN THE SYNOVIUM OF PATIENTS WITH RHEUMATOID ARTHRITIS COMPARED WITH PATIENTS WITHYERSINIA-INDUCED ARTHRITIS AND OSTEOARTHRITIS
1997
The design of a prospective study of pravastatin in the elderly at risk (PROSPER)
1999
Diurnal changes in heparin effect during continuous constant‐rate infusion. A study in nine patients with venous thromboembolism
1994
Expression of Adhesion Molecules in Early Rheumatoid Synovial Tissue
1995
Reduction of Plasma Leptin Levels and Loss of Its Circadian Rhythmicity in Hypocretin (Orexin)-Deficient Narcoleptic Humans
2002
Decrease in cellularity and expression of adhesion molecules by anti–tumor necrosis factor α monoclonal antibody treatment in patients with rheumatoid arthritis
1996
Food Choice in Hyperthyroidism: Potential Influence of the Autonomic Nervous System and Brain Serotonin Precursor Availability
2001
Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity
1997
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
2002 Standout
Management of severe hyponatremia: Rapid or slow correction?
1990
Total cholesterol and risk of mortality in the oldest old
1997
Necessity of the assessment of health status in human immunogerontological studies: Evaluation of the senieur protocol
1990
Strong decrease of high sensitivity C-reactive protein with high-dose atorvastatin in patients with type 2 diabetes mellitus
2002
Weight Loss, Weight Maintenance, and Improved Cardiovascular Risk Factors after 2 Years Treatment with Orlistat for Obesity
2000
Effects of recombinant human leptin treatment as an adjunct of moderate energy restriction on body weight, resting energy expenditure and energy intake in obese humans.
2003
Reduction of synovial inflammation after anti‐cd4 monoclonal antibody treatment in early rheumatoid arthritis
1995
Infectious Complications of Central Venous Catheters Increase the Risk of Catheter-Related Thrombosis in Hematology Patients: A Prospective Study
2005
Sympathovagal imbalance in hyperthyroidism
2001
No Effect of Statin Therapy on Silent Myocardial Ischemia in Patients With Type 2 Diabetes Without Manifest Cardiovascular Disease
2005
The Effect of Statin Therapy on Endothelial Function in Type 2 Diabetes Without Manifest Cardiovascular Disease
2005
Short-term high-fat diet increases macrophage markers in skeletal muscle accompanied by impaired insulin signalling in healthy male subjects
2014
Effect of insulin resistance, apoE2 allele, and smoking on combined hyperlipidemia.
1994
Cerebrovascular Reactivity in Comatose Patients Resuscitated From a Cardiac Arrest
1997
Two-Year Statin Therapy Does Not Alter the Progression of Intima-Media Thickness in Patients With Type 2 Diabetes Without Manifest Cardiovascular Disease
2004
No Effect of Consumption of Green and Black Tea on Plasma Lipid and Antioxidant Levels and on LDL Oxidation in Smokers
1998